// App-Quantinova.ai

P325 : A KINASE-DEAD VARIANT OF CDK6 IS ASSOCIATED WITH REDUCED TUMORIGENIC POTENTIAL AND A DISTINCT TRANSCRIPTIONAL REWIRING IN AN ALL MODEL

Researchers

Presenter

  • Thorsten Klampfl

Principal Investigators

  • Sofie Nebenfhr

  • Florian Bellutti

  • Veronika Sexl

  • Karoline Kollmann

Medical Centers

  • Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria

  • Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria

  • Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria

  • Institu

Locations

  • United States

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cyclin dependent kinase 6

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved